Article

Clinicopathological and molecular features of non-small cell lung cancer that transform to small-cell lung cancer

2023-07-26

Abstract excerpt

The resistance of epidermal growth factor receptor-mutated non-small cell lung cancer (NSCLC) to tyrosine kinase inhibitors has been confirmed to be partially mediated by histological transformation to small-cell lung cancer (SCLC). NSCLC in patients treated with immunotherapy and chemotherapy can also transform into SCLC. However, clinicopathological features and the molecular pathogenesis of patients with transf...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 19815cc8-391f-5f0e-aa3a-4af128e5a98b
DOI: 10.21203/rs.3.rs-3153974/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Clinicopathological and molecular features of non-small cell lung cancer that transform to small-cell lung cancerDOI 10.21203/rs.3.rs-3153974/v1Read

Clinicopathological and molecular features of non-small cell lung cancer without TKI therapy that transforms into small-cell lung cancerSemantic proximity Read

Current knowledge of small cell lung cancer transformation from non-small cell lung cancer.Semantic proximity Read

Small cell lung cancer transformation: From pathogenesis to treatment.Semantic proximity Read

Small cell lung cancer transformations from non-small cell lung cancer: Biological mechanism and clinical relevanceSemantic proximity Read

Genomic alterations and clinical outcomes in patients with lung adenocarcinoma with transformation to small cell lung cancer after treatment with EGFR tyrosine kinase inhibitors: A multicenter retrospective study.Semantic proximity Read

[Research Advances on Transformation to Small Cell Lung Cancer].Semantic proximity Read

Comprehensive molecular and clinical insights into non-small cell lung cancer transformation to small cell lung cancer with an illustrative case report.Semantic proximity Read

Molecular mechanisms and therapeutic strategies for small‑cell lung cancer transformation after TKI therapy in EGFR‑mutated lung adenocarcinoma (Review)Semantic proximity Read

Small Cell Lung Cancer Transformation following Treatment in EGFR-Mutated Non-Small Cell Lung CancerSemantic proximity Read

Case report: TP53 and RB1 loss may facilitate the transformation from lung adenocarcinoma to small cell lung cancer by expressing neuroendocrine markersSemantic proximity Read

Small cell transformation of non-small cell lung cancer under immunotherapy: Case series and literature review.Semantic proximity Read

Transformation from non-small-cell lung cancer to small-cell lung cancer: molecular drivers and cells of origin.Semantic proximity Read